Home / Drug shortages / Phenoxybenzamine Hydrochloride Capsule

Phenoxybenzamine Hydrochloride Capsule — FDA Drug Shortage

To Be Discontinued — Advanz Pharma (US) Corp.

The FDA lists a drug shortage record for Phenoxybenzamine Hydrochloride Capsule (capsule) from Advanz Pharma (US) Corp. with status To Be Discontinued. The shortage was first posted on 12/01/2025.

Shortage Details

Status
To Be Discontinued
Company
Advanz Pharma (US) Corp.
Package NDC
66993-066-02
Dosage Form
Capsule
Presentation
Dibenzyline, Capsule, 10 mg (NDC 66993-066-02)
Initial Posting
12/01/2025
Revised Date

FDA data resources